Literature DB >> 25563365

Knockdown of NF-κB p65 subunit expression suppresses growth of nude mouse lung tumor cell xenografts by activation of Bax apoptotic pathway.

Y Qu, X Zhang, R Wu.   

Abstract

UNLABELLED: Nuclear factor-kappaB (NF-κB) is an important transcriptional factor and regulates a variety of pathophysiologic process involved in cell survival and death. The present study assesses the effects of NF-κB p65 subunit knockdown in suppression of nude mouse lung tumor cell xenografts and understands the underlying molecular events.A nude mouse Lewis lung carcinoma cell xenograft model was established and the mice were intraperitoneally injected with NF-κB p65 siRNA and sacrificed after two weeks of tumor cell injection. Tumor xenografts were harvested for TUNEL, Western blot, and qRT-PCR analyses.Compared to the PBS-treated or the negative control (NC) siRNA-treated mice, tumor xenograft weight and volume was significantly decreased in the NF-κB p65 siRNA-treated mice. The TUNEL positive (apoptosis) cells in xenograft sections were 45 ± 5 in PBS and 38 ± 3 in NC siRNA, but increased to 271 ± 11 in p65 siRNA-treated mice. Compared to the PBS or the NC mice, levels of Bax mRNA and protein in tumor xenografts were significantly upregulated in p65 siRNA-treated mice. Knockdown of NF-κB p65 subunit expression significantly inhibited the growth of nude mouse Lewis tumor cell xenografts by induction of tumor cell apoptosis and significantly up-regulation of pro-apoptotic protein Bax expression. Future study will confirm the current data and targeting NF-κB p65 subunit expression as a potential therapeutic strategy in treating human lung cancer. KEYWORDS: NF-κB, lung cancer, apoptosis, small interfering RNA, xenografts.

Entities:  

Year:  2015        PMID: 25563365     DOI: 10.4149/neo_2015_005

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  8 in total

1.  Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity.

Authors:  Qiusha Tang; Mudan Lu; Huan Zhou; Daozhen Chen; Lu Liu
Journal:  Oncol Lett       Date:  2016-11-24       Impact factor: 2.967

2.  Apoptosis of human pancreatic carcinoma cell-1 cells induced by Yin Chen Hao Decoction.

Authors:  Hai-Bo Zhou; Jing-Ming Chen; Li-Ming Shao; Zhi-Gang Chen
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

3.  Gambogenic acid inhibits LPS-simulated inflammatory response by suppressing NF-κB and MAPK in macrophages.

Authors:  Xianjun Yu; Qun Zhao; Haiwei Zhang; Cunxian Fan; Xixi Zhang; Qun Xie; Chengxian Xu; Yongbo Liu; Xiaoxia Wu; Quanbin Han; Haibing Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-29       Impact factor: 3.848

4.  Suppressing Receptor-Interacting Protein 140: a New Sight for Salidroside to Treat Cerebral Ischemia.

Authors:  Tong Chen; Zhanqiang Ma; Lingpeng Zhu; Wenjiao Jiang; Tingting Wei; Rui Zhou; Fen Luo; Kai Zhang; Qiang Fu; Chunhua Ma; Tianhua Yan
Journal:  Mol Neurobiol       Date:  2015-11-13       Impact factor: 5.590

5.  KPC1 alleviates hypoxia/reoxygenation-induced apoptosis in rat cardiomyocyte cells though BAX degradation.

Authors:  Ye Yuan; Yong-Yi Wang; Xin Liu; Bin Luo; Lei Zhang; Fei Zheng; Xing-Yuan Li; Ling-Yun Guo; Lu Wang; Miao Jiang; Ya-Mu Pan; Yu-Wen Yan; Jian-Ye Yang; Shi-You Chen; Jia-Ning Wang; Jun-Ming Tang
Journal:  J Cell Physiol       Date:  2019-05-30       Impact factor: 6.384

6.  FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.

Authors:  Libin Ma; Huadong He; Kang Jiang; Peiwu Jiang; Han He; Shengjia Feng; Kean Chen; Jia Shao; Gang Deng
Journal:  Aging (Albany NY)       Date:  2020-04-13       Impact factor: 5.682

7.  Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma.

Authors:  Jiawu Wang; Chengyao Zhang; Yan Wu; Weiyang He; Xin Gou
Journal:  Cancer Cell Int       Date:  2019-12-03       Impact factor: 5.722

8.  Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis.

Authors:  M S Sinto; Shaji Thomas; S Kannan
Journal:  Med Oncol       Date:  2021-08-06       Impact factor: 3.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.